Analyst Reco. Curis, Inc.

Equities

CRIS

US2312693094

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-02 EDT			5-day change	1st Jan Change
16.51 ^USD	+3.25%		+13.71%	+29.49%

02-09	HC Wainwright Adjusts Price Target on Curis to $26 From $51, Maintains Buy Rating	MT
02-08	Curis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on Curis to $26 From $51, Maintains Buy Rating	02-09	MT
Truist Starts Curis With Buy Rating	11-17	MT
HC Wainwright Cuts Price Target on Curis to $6 From $9, Maintains Buy Rating	23-07-07	MT
HC Wainwright Lowers Price Target on Curis to $9 From $16, Maintains Buy Rating	22-11-10	MT
B. Riley Lowers Curis' Price Target to $10 from $22, Says Emavusertib on Partial Hold but Still Promising; Keeps Buy Rating	22-04-05	MT
Raymond James Downgrades Curis to Market Perform From Outperform	22-04-04	MT
CURIS : Raymond James Starts Curis at Outperform with $15 Price Target	21-10-13	MT
CURIS : Cantor Fitzgerald Adjusts Curis' Price Target to $24 From $15, Maintains Overweight Rating	21-05-13	MT
CURIS : B. Riley Raises Curis' PT to $22 from $19, Notes Room for Further Upside at European Hematology Association Meeting; Keeps Buy Rating	21-05-13	MT
CURIS : B. Riley Starts Curis at Buy with $19 Price Target	21-03-25	MT
CURIS : HC Wainwright Adjusts Curis' Price Target to $16 From $9, Keeps at Buy	21-01-15	MT
CURIS : HC Wainwright Adjusts Curis' Price Target to $9 From $5, Reiterates Buy Rating	20-12-08	MT
CURIS : HC Wainwright Starts Curis at Buy With $5 Price Target	20-11-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer